We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIOT icon
7476
Riot Platforms
RIOT
$8.04B
$1K ﹤0.01%
+600
New +$1.33K
SAND
7477
DELISTED
Sandstorm Gold
SAND
$1K ﹤0.01%
181
-3,235
-95% -$13.1K
SCHR
7478
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$1K ﹤0.01%
28
-1,790
-98% -$46.5K
SID icon
7479
Companhia Siderúrgica Nacional
SID
$1.47B
$1K ﹤0.01%
417
SLS icon
7480
CALL
SELLAS Life Sciences
SLS
$2.12B
$1K ﹤0.01%
10
SLS icon
7481
SELLAS Life Sciences
SLS
$2.12B
$1K ﹤0.01%
12
SSBI icon
7482
Summit State Bank
SSBI
$89.2M
$1K ﹤0.01%
+69
New +$808
SSKN
7483
DELISTED
Strata Skin Sciences
SSKN
$1K ﹤0.01%
40
STKL
7484
DELISTED
SunOpta
STKL
$1K ﹤0.01%
200
STNG icon
7485
PUT
Scorpio Tankers
STNG
$3.9B
$1K ﹤0.01%
50
SVM
7486
Silvercorp Metals
SVM
$2.14B
$1K ﹤0.01%
433
+6
+1% +$13
TPST icon
7487
Tempest Therapeutics
TPST
$15.3M
$1K ﹤0.01%
1
TURN
7488
DELISTED
180 Degree Capital
TURN
$1K ﹤0.01%
222
-222
-50% -$1.34K
URA icon
7489
Global X Uranium ETF
URA
$5.54B
$1K ﹤0.01%
62
+46
+288% +$573
VALU icon
7490
Value Line
VALU
$352M
$1K ﹤0.01%
39
-259
-87% -$6.46K
VERO
7491
DELISTED
Venus Concept
VERO
0
WPRT
7492
Westport Fuel Systems
WPRT
$34.4M
$1K ﹤0.01%
50
NDP
7493
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$1K ﹤0.01%
25
-10
-29% -$785
WPS
7494
DELISTED
iShares International Developed Property ETF
WPS
$1K ﹤0.01%
24
FSD
7495
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$1K ﹤0.01%
40
-75,343
-100% -$1.05M
EIGR
7496
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1K ﹤0.01%
4
VJET
7497
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$1K ﹤0.01%
160
+20
+14% +$264
VST.WS.A
7498
CALL
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$1K ﹤0.01%
609
ONCT
7499
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1K ﹤0.01%
10
-1
-9% -$200
APRN
7500
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$1K ﹤0.01%
4

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.